News Duchenne drug available in England within weeks after NICE a... NHS England struck deal speeding access to drug.
Digital and Social Media NHS Innovation Accelerator Summit highlights digital pioneer... Healthcare social network and youth gaming developer among those honoured.
Pharma Market Access Accelerated Access Review: no panacea for UK pharma What can the AAR do for the UK pharma industry, the health service and patients?
News NHS under fire for delaying access to rare disease cholester... Pharma concerned by fairness and transparency of NHS England's Prioritisation Framework
Articles NICE calls the shots on Harvoni – but NHS England eyeing pri... Harvoni and rival hep C drugs look set for approval in England – but NHS England may have the last word on controlling costs, finds Andrew McConaghie.
Articles Market access for specialist medicines in the UK: the Price ... A recent pharmaphorum webinar brought four experts together to discuss the future of market access for specialist medicines in the UK.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
